Subscribe to Newsletter
Subspecialties Microbiology and immunology

MSI testing in today's pathology lab: aiming for accuracy and breadth to facilitate optimal therapeutic decision making in oncology

sponsored by Invitae

Available On-Demand

28th October 2021, 4:30pm CEST

Microsatellite instability (MSI) is a well-established biomarker in the diagnosis and prognosis of malignancies and, more recently, a predictive biomarker of response to immunotherapy. Hence, an accurate definition of MSI status is crucial for treatment decisions and patient outcomes. In this webinar, we will review the root causes of MSI at the molecular level and the techniques that exist today in the pathologist toolbox to assess it, each with their advantages and disadvantages. Additionally, we will review current guidelines and recommendations for MSI testing in solid tumors. Finally, we will introduce VariantPlex, Invitae’s NGS research platform, now including expanded gene content and MSI reporting for more comprehensive decision making in oncology.

Available On-Demand

Visit our Webinar Hub

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine